img

Global Gene Editing Technology Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Gene Editing Technology Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism.
Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations
Due to the COVID-19 pandemic, the global Gene Editing Technology market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the forecast period 2023-2033. Fully considering the economic change by this health crisis, Homologous Recombination accounting for % of the Gene Editing Technology global market in 2023, is projected to value US$ million by 2033, growing at a revised % CAGR from 2023 to 2033. While Agriculture segment is altered to an % CAGR throughout this forecast period.
The global key companies of Gene Editing Technology include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech and Recombinetics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
The United States Gene Editing Technology market size was US$ million in 2023, while China size was US$ million. The proportion of the United States was % in 2023, while China percentage was %, and it is predicted that China share will reach % in 2033, trailing a CAGR of % through the analysis period. As for the Europe Gene Editing Technology landscape, Germany is projected to reach US$ million by 2033. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Gene Editing Technology market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Gene Editing Technology market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Gene Editing Technology market. Readers of the report can become informed about current and future trends of the global Gene Editing Technology market and how they will impact market growth during the forecast period.



By Company


Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Segment by Type
Homologous Recombination
Meganuclease

Segment by Application


Agriculture
Medical
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Gene Editing Technology in global and regional level.
Chapter 3Detailed analysis of Gene Editing Technology companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Editing Technology revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Technology Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Homologous Recombination
1.2.3 Meganuclease
1.3 Market by Application
1.3.1 Global Gene Editing Technology Market Growth Rate by Application: 2018 VS 2023 VS 2033
1.3.2 Agriculture
1.3.3 Medical
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Gene Editing Technology Market Size (2018-2033)
2.2 Gene Editing Technology Market Size across Key Geographies Worldwide: 2018 VS 2023 VS 2033
2.3 Global Gene Editing Technology Market Size by Region (2018-2023)
2.4 Global Gene Editing Technology Market Size Forecast by Region (2024-2033)
2.5 Global Top 10 Gene Editing Technology Countries Ranking by Market Size
3 Gene Editing Technology Competitive by Company
3.1 Global Gene Editing Technology Revenue by Players
3.1.1 Global Gene Editing Technology Revenue by Players (2018-2023)
3.1.2 Global Gene Editing Technology Market Share by Players (2018-2023)
3.2 Global Gene Editing Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Gene Editing Technology Revenue
3.4 Global Gene Editing Technology Market Concentration Ratio
3.4.1 Global Gene Editing Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Technology Revenue in 2023
3.5 Global Key Players of Gene Editing Technology Head office and Area Served
3.6 Global Key Players of Gene Editing Technology, Product and Application
3.7 Global Key Players of Gene Editing Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Gene Editing Technology Breakdown Data by Type
4.1 Global Gene Editing Technology Historic Revenue by Type (2018-2023)
4.2 Global Gene Editing Technology Forecasted Revenue by Type (2024-2033)
5 Global Gene Editing Technology Breakdown Data by Application
5.1 Global Gene Editing Technology Historic Market Size by Application (2018-2023)
5.2 Global Gene Editing Technology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gene Editing Technology Revenue by Company (2021-2023)
6.2 North America Gene Editing Technology Revenue by Type (2018-2033)
6.3 North America Gene Editing Technology Revenue by Application (2018-2033)
6.4 North America Gene Editing Technology Revenue by Country (2018-2033)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Gene Editing Technology Revenue by Company (2021-2023)
7.2 Europe Gene Editing Technology Revenue by Type (2018-2033)
7.3 Europe Gene Editing Technology Revenue by Application (2018-2033)
7.4 Europe Gene Editing Technology Revenue by Country (2018-2033)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Gene Editing Technology Revenue by Company (2021-2023)
8.2 Asia Pacific Gene Editing Technology Revenue by Type (2018-2033)
8.3 Asia Pacific Gene Editing Technology Revenue by Application (2018-2033)
8.4 Asia Pacific Gene Editing Technology Revenue by Region (2018-2033)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Gene Editing Technology Revenue by Company (2021-2023)
9.2 Latin America Gene Editing Technology Revenue by Type (2018-2033)
9.3 Latin America Gene Editing Technology Revenue by Application (2018-2033)
9.4 Latin America Gene Editing Technology Revenue by Country (2018-2033)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gene Editing Technology Revenue by Company (2021-2023)
10.2 Middle East and Africa Gene Editing Technology Revenue by Type (2018-2033)
10.3 Middle East and Africa Gene Editing Technology Revenue by Application (2018-2033)
10.4 Middle East and Africa Gene Editing Technology Revenue by Country (2018-2033)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Editing Technology Products and Services
11.1.4 Thermo Fisher Scientific Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.1.5 Thermo Fisher Scientific Gene Editing Technology SWOT Analysis
11.1.6 Thermo Fisher Scientific Recent Development
11.2 SIGMA ALDRICH
11.2.1 SIGMA ALDRICH Company Details
11.2.2 SIGMA ALDRICH Business Overview
11.2.3 SIGMA ALDRICH Gene Editing Technology Products and Services
11.2.4 SIGMA ALDRICH Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.2.5 SIGMA ALDRICH Gene Editing Technology SWOT Analysis
11.2.6 SIGMA ALDRICH Recent Development
11.3 Dharmacon
11.3.1 Dharmacon Company Details
11.3.2 Dharmacon Business Overview
11.3.3 Dharmacon Gene Editing Technology Products and Services
11.3.4 Dharmacon Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.3.5 Dharmacon Gene Editing Technology SWOT Analysis
11.3.6 Dharmacon Recent Development
11.4 Cellectics
11.4.1 Cellectics Company Details
11.4.2 Cellectics Business Overview
11.4.3 Cellectics Gene Editing Technology Products and Services
11.4.4 Cellectics Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.4.5 Cellectics Gene Editing Technology SWOT Analysis
11.4.6 Cellectics Recent Development
11.5 CRISPR Therapeutics
11.5.1 CRISPR Therapeutics Company Details
11.5.2 CRISPR Therapeutics Business Overview
11.5.3 CRISPR Therapeutics Gene Editing Technology Products and Services
11.5.4 CRISPR Therapeutics Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.5.5 CRISPR Therapeutics Gene Editing Technology SWOT Analysis
11.5.6 CRISPR Therapeutics Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Gene Editing Technology Products and Services
11.6.4 AstraZeneca Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.6.5 AstraZeneca Gene Editing Technology SWOT Analysis
11.6.6 AstraZeneca Recent Development
11.7 Bio Rad
11.7.1 Bio Rad Company Details
11.7.2 Bio Rad Business Overview
11.7.3 Bio Rad Gene Editing Technology Products and Services
11.7.4 Bio Rad Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.7.5 Bio Rad Gene Editing Technology SWOT Analysis
11.7.6 Bio Rad Recent Development
11.8 Allele Biotech
11.8.1 Allele Biotech Company Details
11.8.2 Allele Biotech Business Overview
11.8.3 Allele Biotech Gene Editing Technology Products and Services
11.8.4 Allele Biotech Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.8.5 Allele Biotech Gene Editing Technology SWOT Analysis
11.8.6 Allele Biotech Recent Development
11.9 Recombinetics
11.9.1 Recombinetics Company Details
11.9.2 Recombinetics Business Overview
11.9.3 Recombinetics Gene Editing Technology Products and Services
11.9.4 Recombinetics Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.9.5 Recombinetics Gene Editing Technology SWOT Analysis
11.9.6 Recombinetics Recent Development
11.10 Lonza
11.10.1 Lonza Company Details
11.10.2 Lonza Business Overview
11.10.3 Lonza Gene Editing Technology Products and Services
11.10.4 Lonza Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.10.5 Lonza Gene Editing Technology SWOT Analysis
11.10.6 Lonza Recent Development
11.11 GE Healthcare
11.11.1 GE Healthcare Company Details
11.11.2 GE Healthcare Business Overview
11.11.3 GE Healthcare Gene Editing Technology Products and Services
11.11.4 GE Healthcare Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.11.5 GE Healthcare Recent Development
11.12 Editas Medicine
11.12.1 Editas Medicine Company Details
11.12.2 Editas Medicine Business Overview
11.12.3 Editas Medicine Gene Editing Technology Products and Services
11.12.4 Editas Medicine Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.12.5 Editas Medicine Recent Development
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Details
11.13.2 Agilent Technologies Business Overview
11.13.3 Agilent Technologies Gene Editing Technology Products and Services
11.13.4 Agilent Technologies Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.13.5 Agilent Technologies Recent Development
11.14 QIAGEN NV
11.14.1 QIAGEN NV Company Details
11.14.2 QIAGEN NV Business Overview
11.14.3 QIAGEN NV Gene Editing Technology Products and Services
11.14.4 QIAGEN NV Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023)
11.14.5 QIAGEN NV Recent Development
12 Gene Editing Technology Market Dynamics
12.1 Gene Editing Technology Industry Trends
12.2 Gene Editing Technology Market Drivers
12.3 Gene Editing Technology Market Challenges
12.4 Gene Editing Technology Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Gene Editing Technology Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Homologous Recombination
Table 3. Key Players of Meganuclease
Table 4. Global Gene Editing Technology Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 5. Global Gene Editing Technology Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2023 VS 2033
Table 6. Global Gene Editing Technology Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Gene Editing Technology Revenue Forecast by Region (2024-2033) & (US$ Million)
Table 8. Global Gene Editing Technology Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Table 9. Global Gene Editing Technology Revenue by Players (2018-2023) & (US$ Million)
Table 10. Global Gene Editing Technology Market Share by Players (2018-2023)
Table 11. Global Top Gene Editing Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Technology as of 2023)
Table 12. Ranking of Global Top Gene Editing Technology Companies by Revenue (US$ Million) in 2023
Table 13. Global 5 Largest Players Market Share by Gene Editing Technology Revenue (CR5 and HHI) & (2018-2023)
Table 14. Global Key Players of Gene Editing Technology, Headquarters and Area Served
Table 15. Global Key Players of Gene Editing Technology, Product and Application
Table 16. Global Key Players of Gene Editing Technology, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Gene Editing Technology Market Size by Type (2018-2023) & (US$ Million)
Table 19. Global Gene Editing Technology Revenue Market Share by Type (2018-2023)
Table 20. Global Gene Editing Technology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 21. Global Gene Editing Technology Revenue Market Share by Type (2024-2033)
Table 22. Global Gene Editing Technology Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Gene Editing Technology Revenue Market Share by Application (2018-2023)
Table 24. Global Gene Editing Technology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Gene Editing Technology Revenue Market Share by Application (2024-2033)
Table 26. North America Gene Editing Technology Revenue by Company (2021-2023) & (US$ Million)
Table 27. North America Gene Editing Technology Revenue by Type (2018-2023) & (US$ Million)
Table 28. North America Gene Editing Technology Revenue by Type (2024-2033) & (US$ Million)
Table 29. North America Gene Editing Technology Revenue by Application (2018-2023) & (US$ Million)
Table 30. North America Gene Editing Technology Revenue by Application (2024-2033) & (US$ Million)
Table 31. North America Gene Editing Technology Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 32. North America Gene Editing Technology Revenue by Country (2018-2023) & (US$ Million)
Table 33. North America Gene Editing Technology Revenue by Country (2024-2033) & (US$ Million)
Table 34. Europe Gene Editing Technology Revenue by Company (2021-2023) & (US$ Million)
Table 35. Europe Gene Editing Technology Revenue by Type (2018-2023) & (US$ Million)
Table 36. Europe Gene Editing Technology Revenue by Type (2024-2033) & (US$ Million)
Table 37. Europe Gene Editing Technology Revenue by Application (2018-2023) & (US$ Million)
Table 38. Europe Gene Editing Technology Revenue by Application (2024-2033) & (US$ Million)
Table 39. Europe Gene Editing Technology Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 40. Europe Gene Editing Technology Revenue by Country (2018-2023) & (US$ Million)
Table 41. Europe Gene Editing Technology Revenue by Country (2024-2033) & (US$ Million)
Table 42. Asia Pacific Gene Editing Technology Revenue by Company (2021-2023) & (US$ Million)
Table 43. Asia Pacific Gene Editing Technology Revenue by Type (2018-2023) & (US$ Million)
Table 44. Asia Pacific Gene Editing Technology Revenue by Type (2024-2033) & (US$ Million)
Table 45. Asia Pacific Gene Editing Technology Revenue by Application (2018-2023) & (US$ Million)
Table 46. Asia Pacific Gene Editing Technology Revenue by Application (2024-2033) & (US$ Million)
Table 47. Asia-Pacific Gene Editing Technology Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 48. Asia Pacific Gene Editing Technology Revenue by Region (2018-2023) & (US$ Million)
Table 49. Asia Pacific Gene Editing Technology Revenue by Region (2024-2033) & (US$ Million)
Table 50. Latin America Gene Editing Technology Revenue by Company (2021-2023) & (US$ Million)
Table 51. Latin America Gene Editing Technology Revenue by Type (2018-2023) & (US$ Million)
Table 52. Latin America Gene Editing Technology Revenue by Type (2024-2033) & (US$ Million)
Table 53. Latin America Gene Editing Technology Revenue by Application (2018-2023) & (US$ Million)
Table 54. Latin America Gene Editing Technology Revenue by Application (2024-2033) & (US$ Million)
Table 55. Latin America Gene Editing Technology Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 56. Latin America Gene Editing Technology Revenue by Country (2018-2023) & (US$ Million)
Table 57. Latin America Gene Editing Technology Revenue by Country (2024-2033) & (US$ Million)
Table 58. Middle East and Africa Gene Editing Technology Revenue by Company (2021-2023) & (US$ Million)
Table 59. Middle East and Africa Gene Editing Technology Revenue by Type (2018-2023) & (US$ Million)
Table 60. Middle East and Africa Gene Editing Technology Revenue by Type (2024-2033) & (US$ Million)
Table 61. Middle East and Africa Gene Editing Technology Revenue by Application (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Gene Editing Technology Revenue by Application (2024-2033) & (US$ Million)
Table 63. Middle East and Africa Gene Editing Technology Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 64. Middle East and Africa Gene Editing Technology Revenue by Country (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Gene Editing Technology Revenue by Country (2024-2033) & (US$ Million)
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Gene Editing Technology Product and Services
Table 69. Thermo Fisher Scientific Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 70. Thermo Fisher Scientific Gene Editing Technology SWOT Analysis
Table 71. Thermo Fisher Scientific Recent Development
Table 72. SIGMA ALDRICH Company Details
Table 73. SIGMA ALDRICH Business Overview
Table 74. SIGMA ALDRICH Gene Editing Technology Product and Services
Table 75. SIGMA ALDRICH Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 76. SIGMA ALDRICH Gene Editing Technology SWOT Analysis
Table 77. SIGMA ALDRICH Recent Development
Table 78. Dharmacon Company Details
Table 79. Dharmacon Business Overview
Table 80. Dharmacon Gene Editing Technology Product and Services
Table 81. Dharmacon Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 82. Dharmacon Gene Editing Technology SWOT Analysis
Table 83. Dharmacon Recent Development
Table 84. Cellectics Company Details
Table 85. Cellectics Business Overview
Table 86. Cellectics Gene Editing Technology Product and Services
Table 87. Cellectics Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 88. Cellectics Gene Editing Technology SWOT Analysis
Table 89. Cellectics Recent Development
Table 90. CRISPR Therapeutics Company Details
Table 91. CRISPR Therapeutics Business Overview
Table 92. CRISPR Therapeutics Gene Editing Technology Product and Services
Table 93. CRISPR Therapeutics Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 94. CRISPR Therapeutics Gene Editing Technology SWOT Analysis
Table 95. CRISPR Therapeutics Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Gene Editing Technology Product and Services
Table 99. AstraZeneca Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 100. AstraZeneca Gene Editing Technology SWOT Analysis
Table 101. AstraZeneca Recent Development
Table 102. Bio Rad Company Details
Table 103. Bio Rad Business Overview
Table 104. Bio Rad Gene Editing Technology Product and Services
Table 105. Bio Rad Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 106. Bio Rad Gene Editing Technology SWOT Analysis
Table 107. Bio Rad Recent Development
Table 108. Allele Biotech Company Details
Table 109. Allele Biotech Business Overview
Table 110. Allele Biotech Gene Editing Technology Product and Services
Table 111. Allele Biotech Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 112. Allele Biotech Gene Editing Technology SWOT Analysis
Table 113. Allele Biotech Recent Development
Table 114. Recombinetics Company Details
Table 115. Recombinetics Business Overview
Table 116. Recombinetics Gene Editing Technology Product and Services
Table 117. Recombinetics Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 118. Recombinetics Gene Editing Technology SWOT Analysis
Table 119. Recombinetics Recent Development
Table 120. Lonza Company Details
Table 121. Lonza Business Overview
Table 122. Lonza Gene Editing Technology Product and Services
Table 123. Lonza Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 124. Lonza Gene Editing Technology SWOT Analysis
Table 125. Lonza Recent Development
Table 126. GE Healthcare Company Details
Table 127. GE Healthcare Business Overview
Table 128. GE Healthcare Gene Editing Technology Product and Services
Table 129. GE Healthcare Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 130. GE Healthcare Recent Development
Table 131. Editas Medicine Company Details
Table 132. Editas Medicine Business Overview
Table 133. Editas Medicine Gene Editing Technology Product and Services
Table 134. Editas Medicine Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 135. Editas Medicine Recent Development
Table 136. Agilent Technologies Company Details
Table 137. Agilent Technologies Business Overview
Table 138. Agilent Technologies Gene Editing Technology Product and Services
Table 139. Agilent Technologies Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 140. Agilent Technologies Recent Development
Table 141. QIAGEN NV Company Details
Table 142. QIAGEN NV Business Overview
Table 143. QIAGEN NV Gene Editing Technology Product and Services
Table 144. QIAGEN NV Gene Editing Technology Revenue in Gene Editing Technology Business (2018-2023) & (US$ Million)
Table 145. QIAGEN NV Recent Development
Table 146. Gene Editing Technology Market Trends
Table 147. Gene Editing Technology Market Drivers
Table 148. Gene Editing Technology Market Challenges
Table 149. Gene Editing Technology Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Editing Technology Product Picture
Figure 2. Global Gene Editing Technology Market Size by Type (US$ Million): 2018 VS 2023 VS 2033
Figure 3. Global Gene Editing Technology Market Share by Type: 2023 VS 2033
Figure 4. Homologous Recombination Features
Figure 5. Meganuclease Features
Figure 6. Global Gene Editing Technology Market Size by Application (US$ Million): 2018 VS 2023 VS 2033
Figure 7. Global Gene Editing Technology Market Share by Application: 2023 VS 2033
Figure 8. Agriculture
Figure 9. Medical
Figure 10. Other
Figure 11. Gene Editing Technology Report Years Considered
Figure 12. Global Gene Editing Technology Revenue, (US$ Million), 2018 VS 2023 VS 2033
Figure 13. Global Gene Editing Technology Market Size 2018-2033 (US$ Million)
Figure 14. Global Gene Editing Technology Market Size Market Share by Region: 2023 VS 2033
Figure 15. Global Gene Editing Technology Revenue Market Share by Region in 2018 VS 2023
Figure 16. Global Gene Editing Technology Revenue Market Share Forecast by Region (2024-2033)
Figure 17. Global Top 10 Gene Editing Technology Countries Ranking by Market Size (US$ Million) in 2023
Figure 18. Global Gene Editing Technology Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Figure 19. Global Gene Editing Technology Market Share by Players in 2023
Figure 20. Global Top Gene Editing Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing Technology as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Gene Editing Technology Revenue in 2023
Figure 22. North America Gene Editing Technology Revenue Market Share by Company in 2023
Figure 23. North America Gene Editing Technology Revenue Market Share by Type (2018-2033)
Figure 24. North America Gene Editing Technology Revenue Market Share by Application (2018-2033)
Figure 25. North America Gene Editing Technology Revenue Share by Country (2018-2033)
Figure 26. United States Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 27. Canada Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 28. Europe Gene Editing Technology Revenue Market Share by Company in 2023
Figure 29. Europe Gene Editing Technology Revenue Market Share by Type (2018-2033)
Figure 30. Europe Gene Editing Technology Revenue Market Share by Application (2018-2033)
Figure 31. Europe Gene Editing Technology Revenue Share by Country (2018-2033)
Figure 32. Germany Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 33. France Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 34. U.K. Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 35. Italy Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 36. Russia Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 37. Asia Pacific Gene Editing Technology Revenue Market Share by Company in 2023
Figure 38. Asia Pacific Gene Editing Technology Revenue Market Share by Type (2018-2033)
Figure 39. Asia Pacific Gene Editing Technology Revenue Market Share by Application (2018-2033)
Figure 40. Asia Pacific Gene Editing Technology Revenue Share by Region (2018-2033)
Figure 41. China Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 42. Japan Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 43. South Korea Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 44. India Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 45. Australia Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 46. China Taiwan Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 47. Indonesia Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 48. Thailand Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 49. Malaysia Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 50. Latin America Gene Editing Technology Revenue Market Share by Company in 2023
Figure 51. Latin America Gene Editing Technology Revenue Market Share by Type (2018-2033)
Figure 52. Latin America Gene Editing Technology Revenue Market Share by Application (2018-2033)
Figure 53. Latin America Gene Editing Technology Revenue Share by Country (2018-2033)
Figure 54. Mexico Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 55. Brazil Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 56. Argentina Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 57. Middle East and Africa Gene Editing Technology Revenue Market Share by Company in 2023
Figure 58. Middle East and Africa Gene Editing Technology Revenue Market Share by Type (2018-2033)
Figure 59. Middle East and Africa Gene Editing Technology Revenue Market Share by Application (2018-2033)
Figure 60. Middle East and Africa Gene Editing Technology Revenue Share by Country (2018-2033)
Figure 61. Turkey Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 62. Saudi Arabia Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 63. UAE Gene Editing Technology Revenue (2018-2033) & (US$ Million)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 65. SIGMA ALDRICH Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 66. Dharmacon Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 67. Cellectics Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 68. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 69. AstraZeneca Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 70. Bio Rad Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 71. Allele Biotech Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 72. Recombinetics Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 73. Lonza Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 74. GE Healthcare Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 75. Editas Medicine Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 76. Agilent Technologies Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 77. QIAGEN NV Revenue Growth Rate in Gene Editing Technology Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries